Stay Updated with the Latest UNO Minda Limited UNOMINDA.BO News in Real Time
Find UNOMINDA.BO news now at Meyka AI. Stay informed with the latest UNO Minda Limited stocks updates, including price news, market analysis, and expert insights.
Vimeo Owner Bending Spoons Prices $1.68 Billion IPO Above Range Ahead of U.S. Market Debut
Bending Spoons has made a strong entrance into the U.S. public market by pricing its initial public offering above the expected range on July 1, 2026. The Italian software company raised $1.68 billion, signaling robust investor demand despite a cautious IPO environment. Known for acquiring well-known digital platforms like Vimeo, the company is drawing global…
Student Loan Overhaul Takes Effect: New Borrowing Limits and Repayment Rules Explained for Students and Parents
On July 1, 2026, major changes to federal student loans officially take effect in the United States. The overhaul reshapes how millions of students and parents borrow and repay education debt. It comes at a time when student loan debt has reached about $1.7 trillion nationwide. New limits, updated repayment rules, and fewer loan options…
FTSE 100 Drops 0.29% Amid Fresh Iran-Qatar Mediation Efforts and Uncertainty Over Inflation Path
The FTSE 100 dropped 0.29% in early trading as investors weighed fresh diplomatic efforts between Iran and Qatar against ongoing concerns over the UK’s inflation outlook. The market remained cautious despite signs of easing geopolitical tensions, with attention shifting to upcoming economic data and the outlook for interest rates. As of late June 2026, uncertainty…
HUDCO (NSE: HUDCO) Shares Jump Over 3% as Q1 Loan Sanctions Surge 93% YoY to ₹65,485 Crore
Housing and Urban Development Corporation (HUDCO) began FY2026-27 on a strong note with provisional Q1 business numbers released on July 1, 2026. The state-owned lender reported a 93% year-on-year jump in loan sanctions to ₹65,485 crore, while loan disbursements also posted solid growth. The update pushed HUDCO shares up more than 3% in early trade,…
Tata Elxsi (NSE: TATAELXSI) and Tata Technologies Shares Fall Up to 6% as KPIT’s Weak Q1FY27 Outlook Weighs on Sentiment
On July 1, 2026, shares of Tata Elxsi and Tata Technologies dropped by up to 6% after KPIT Technologies issued a weaker-than-expected business outlook for Q1FY27. The update raised fresh concerns about slowing demand in the global automotive technology sector, especially from European carmakers. Although the Tata companies made no negative announcements of their own,…
KPIT Technologies Share Price Slides 15% to ₹570 After Weak Q1 FY27 Business Update
KPIT Technologies shares crashed to a fresh 52-week low on July 1, 2026. The stock hit ₹570.75 on the BSE, a 15% intraday decline from the previous session close of ₹671.45 after the Pune-based automotive software company issued a profit warning late on June 30, 2026. KPIT flagged a sudden revenue shortfall in Q1 FY27…
Zee Media Share Price Rises 1% After ₹19.12 Crore Fundraise; FII Upps Stake to 3.33% via Warrant Conversion
Zee Media’s shares rose nearly 1% after the company announced a fresh capital infusion of ₹19.12 crore through warrant conversion. The move also pushed Foreign Institutional Investor (FII) ownership to 3.33%, highlighting growing institutional interest in the media company. The development comes as investors look for signs of recovery and stronger financial positioning in India’s…
Apple Inc News: 5 Billion Devices Affected by AirDrop and Quick Share Security Flaw
Apple Inc (NASDAQ: AAPL) faces fresh scrutiny after researchers disclosed major proximity-sharing vulnerabilities on June 30, 2026. Six AirDrop and Quick Share vulnerabilities span iOS, macOS, Android, and Windows, affecting protocols on over five billion active devices. Researchers at the CISPA Helmholtz Center for Information Security examined both systems and uncovered the flaws. Apple, Google,…
Abivax Shares Soar 27% After Ulcerative Colitis Drug Shows Strong Results in Hard-to-Treat Patients
Abivax shares surged sharply after new clinical trial results for its ulcerative colitis treatment, obefazimod, showed strong performance in patients who previously failed standard therapies. The stock reaction reflects renewed investor confidence in the biotech pipeline and growing hopes for a breakthrough therapy in a difficult disease area. The move also comes at a time…